Back

Targeting ventricular tachycardia originating from the anterolateral papillary muscle with stereotactic body radioablation therapy

1 September 2024 (09:00 - 09:50)
Organised by: Logo
Congress Presentation Part of: Stereotactic-guided and other novel catheter ablative procedures for ventricular arrhythmias Radiotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Meysam Pirbaglou

Partners in Advanced Cardiac Evaluation - Pace Cardiology, Newmarket (Canada)

7 More presentations in this session

Presentation thumbnail
3D target definition and initial results from the electroanatomic substrate-guided stereotactic ablative radiotherapy for refractory ventricular tachycardia (ELSTAR-VT)
Miss Y. Kaya (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Preliminary results of the non-invasive cardiac radioablation for ventricular tachycardia study; an in silico dosimetric comparison of photon vs proton radiotherapy for ventricular arrhythmias
Doctor L. Vicini Scajola (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Cardiac motion in patients with ventricular tachycardia: potential implications for the treatment of patients candidates to stereotactic arrhythmia radio-ablation (STAR)
Doctor L. Vicini Scajola (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Stereotactic arrhythmia radioablation - A systematic review and meta-analysis of the prospective clinical studies
Mr W. Hoeksema (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Machine-learning models to predict the risk of recurrent VT following catheter ablation in patients with structural heart disease
Doctor P. Futela (Cleveland, US)
Abstract Slides Video

Access the full session

Session thumbnail
Stereotactic-guided and other novel catheter ablative procedures for ventricular arrhythmias

The Event

Event poster

ESC Congress 2024

1 September 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Comparative efficacy of stereotactic body radiotherapy versus radiofrequency catheter ablation in refractory ventricular tachyarrhythmia: results from the vt-art consortium
thumbnail
Congress Presentation
Increase in ventricular tachycardia burden during the blanking period after stereotactic arrhythmia radioablation - preliminary results from the CREVET study
thumbnail
Congress Presentation
Cardiac SABR vs. catheter ablation for VT in high-risk IHD patients: early experience from a UK centre

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources